Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: Neutrophil membrane engineered HucMSC sEVs alleviate cisplatin-induced AKI by enhancing cellular uptake and targeting

Fig. 8

NEX inhibits uptake of hucMSC-sEVs by RAW264.7 macrophages. a–e RAW264.7 cellular uptake of DIO-labeled hucMSC-sEVs and NEX was detected by flow cytometry. f Statistical results of flow cytometry at different time points. g RAW264.7 cellular uptake of DIL-labeled hucMSC-sEVs and NEX was detected by the Cytation 5 automatic microplate reader. h Expression of the neutrophil CD47 molecule was detected using western blotting. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us